MC1684 Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, Lymphomas, or Histiocytic/Dendritic Cell Neoplasms

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06508463

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:27:57.773003+00:00

Published At

2026-04-13T00:00:00+00:00

Record Updated At

2026-04-13

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Peripheral T Cell Lymphoma", "Relapsed Peripheral T-Cell Lymphoma", "Peripheral T-Cell Lymphoma, Not Otherwise Specified", "Anaplastic Large Cell Lymphoma", "Mycosis Fungoides", "Relapsed Anaplastic Large Cell Lymphoma", "Relapsed Mycosis Fungoides"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-04-13"

protocolSection.identificationModule.nctId

"NCT06508463"

protocolSection.identificationModule.officialTitle

"MC1684 Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, Lymphomas, or Histiocytic/Dendritic Cell Neoplasms"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Peripheral T Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Relapsed Peripheral T-Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Peripheral T-Cell Lymphoma, Not Otherwise Specified (protocolSection.conditionsModule.conditions)
• Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Mycosis Fungoides (protocolSection.conditionsModule.conditions)
• Relapsed Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Relapsed Mycosis Fungoides (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.